SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-026221
Filing Date
2018-11-01
Accepted
2018-11-01 16:07:41
Documents
3
Period of Report
2018-11-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K omed-8k_20181101.htm 8-K 31539
2 EX-99.1 omed-ex991_6.htm EX-99.1 266257
3 GRAPHIC gdue5qld3evx000001.jpg GRAPHIC 3404
  Complete submission text file 0001564590-18-026221.txt   303746
Mailing Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-995-8200
OncoMed Pharmaceuticals Inc (Filer) CIK: 0001302573 (see all company filings)

IRS No.: 383572512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35993 | Film No.: 181153778
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1